General Information of the Compound
| Compound ID |
CP0410851
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S,5S,8S,11S,14R,19R,22S,25R,28S,34S)-19-[[(2S)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino]-11-benzyl-34-(3-carbamimidamidopropyl)-3,6,9,12,20,23,26,36-octahydroxy-N-[(2S)-1-hydroxy-3-(4-hydroxyphenyl)-1-iminopropan-2-yl]-5-(2-hydroxy-2-iminoethyl)-22-(1H-imidazol-5-ylmethyl)-2-(1H-indol-3-ylmethyl)-8-methyl-25-(naphthalen-2-ylmethyl)-32-oxo-16,17,30-trithia-1,4,7,10,13,21,24,27,35-nonazabicyclo[26.4.4]hexatriaconta-3,6,9,12,20,23,26,35-octaene-14-carboximidic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C81H96N20O15S3
|
||||||||||||||||||
| Molecular Weight |
1685.985
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)N2C[C@H](CCCN=C(N)N)NC(=O)[C@@H](CSCC2=O)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C81H96N20O15S3/c1-44-71(107)94-60(31-45-10-3-2-4-11-45)74(110)100-66(78(114)93-59(70(84)106)30-47-20-25-55(103)26-21-47)41-119-118-40-65(98-72(108)57(82)29-46-18-23-54(102)24-19-46)79(115)96-62(34-53-37-87-43-90-53)76(112)95-61(32-48-17-22-49-12-5-6-13-50(49)28-48)75(111)99-64-39-117-42-69(105)101(38-52(92-77(64)113)14-9-27-88-81(85)86)67(33-51-36-89-58-16-8-7-15-56(51)58)80(116)97-63(35-68(83)104)73(109)91-44/h2-8,10-13,15-26,28,36-37,43-44,52,57,59-67,89,102-103H,9,14,27,29-35,38-42,82H2,1H3,(H2,83,104)(H2,84,106)(H,87,90)(H,91,109)(H,92,113)(H,93,114)(H,94,107)(H,95,112)(H,96,115)(H,97,116)(H,98,108)(H,99,111)(H,100,110)(H4,85,86,88)/t44-,52-,57-,59-,60-,61+,62-,63-,64+,65-,66-,67-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
JSYBMOUNBDELGQ-OBCYGROVSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02450, Melanocortin receptor 3
Protein ID: PT01431, Melanocortin receptor 4
Protein ID: PT01528, Melanocortin receptor 5
Protein ID: PT01440, Melanocyte-stimulating hormone receptor